Week 296 Review - Held my SIPP cash for almost an hour before buying more Caledonia Mining

A really good week, with no major fallers and some decent gains in my larger holdings. That resulted in the deficit between cost and value reducing by £4,575 so it now stands at £19,023, and total portfolio value increased to £120,076.

CMCL:Caledonia Mining announced the completion of their central shaft project and an increased dividend, so with production about to ramp up I decided to put my £1,000 cash into here. That purchase is now in profit, but my overall holding improved by 6% but is still 15% down. I'm hoping for a steady rise and I'll gradually sell off until I have the original £1,000 holding as a long term dividend payer.

DDDD:4D Pharma still haven't achieved the hoped-for gains following the Nasdaq listing, but the impatient traders seem to have moved on and my holding went up 6% this week. The SIPP holding is only 4% down now, but ISA still 11% down and trading account 14% down. That should change after the next news and as DDDD shares are gradually converted to LBPS so the Nasdaq traded shares become more liquid. Investors holding DDDD can convert 8 of them to one LBPS so I'd expect these to increase in number as the DDDD shares are converted. Not sure I could be bothered converting mine, as the DDDD price should just follow LBPS.

POLR:Polar Capital Holdings has been a really good buy, and climbed another 6% this week to go 43% up altogether, or 50% if you include the dividends.

CAML:Central Asia Metals is finally letting rip, with an 11% increase this week taking my holding to 48% up, or 73% if you include the vast dividends. I feel a bit bad about selling some a few weeks ago, but it still makes up 5% of my portfolio.

TLOU:Tlou Energy is starting to look very promising, and my main holding climbed 7% but is still 52% down. However my new SIPP holding climbed 16% of the purchase price and is now 13% up and making £115 potential profit. If the PPA is signed then I think these will rocket.

Share of the Week is JLP:Jubilee Metals which climbed 37% of my original purchase price and is now up by 283%. When this starts going up a penny at a time it may get Share of the Week a lot more often! I just need to resist the temptation to sell more. My potential profit is £7,353, but if I had kept hold of all my shares it would be £18,420. I'm pretty sure the companies I re-invested my £5,467 profits haven't gone up enough to make up the £6,000 shortfall from what I could have had.

Progress in the right direction

Still well below the trend line so some catching up to do.

Here's the ISA and shares portfolio after week 36 of year 6.

			Weekly Change
Cash	£9.79		-£3.75
Portfolio cost	£67,058.62		+£0
Portfolio sell value (bid price-commission)	£57,049.85	(-14.9%)	+£2,318.14
Potential profits	£7,353.67		+£960.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£4,629.22		+£0
Yr 6 projected avg monthly profit	£553.16	(15.9%)	-£16.27
Total Dividends	£1,343.15		+£0
Total Profit from sales	£25,055.83		+£0
Average monthly cash profit	£382.57	(11.0%)	-£1.35
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	63%		+0%

Potential profits up £960 thanks to JLP:Jubilee Metals, and an excellent improvement in value thanks to TLOU:Tlou Energy, DDDD:4D Pharma and OPTI:Optibiotix, the last of which increased by 1p. Cash dropped by monthly ISA fee, and long term performance is still above target, but will be below target if MTFB:Motif Bio don't get their act together and complete their reverse takeover as I'll lose £2,521 from my profits.

Although it's regained some losses, there's still a worrying pattern of decline.

Well below the trend line despite the trend line being well below break even.

The SIPP looks like this after week 280 overall and week 20 of year 6.

			Weekly Change
Cash	£242.22		-£986.51
Portfolio cost	£69,156.07		+£1,006.55
Portfolio sell value (bid price - commission)	£60,862.37	(-12.0%)	+£2,202.82
Potential profits	£4,433.19		+£1,041.75
Yr 6 Dividends	£469.75		+£36.70
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£5,085.38		+£0
Yr 6 projected avg monthly profit	£1,189.09	(33.4%)	-£54.22
Total Dividends	£2,536.83		+£36.70
Total Interest	£0.20		+£0
Total Profit from sales	£20,544.82		+£0
Average monthly cash profit	£346.57	(9.8%)	-£0.68
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		+1%

I tried to hold my £1,000 but when CMCL:Caledonia Mining announced completion of their new central shaft project and an increase in dividend, I had to get some more as this will significantly ramp up production, and I was feeling underweight with gold given the potential for the gold price to increase. I bought another 86 shares at 1160p costing £1,006.55. My total holding cost £3,000 when I only intended to invest £1,000 so I'll probably sell two thirds of them in the not too distant future.

Compound performance was nudged just over 53% by the addition of the £36.70 dividend from APAX:Apax Global Alpha, taking their dividend yield to 7% of my original purchase price, with the share price 32% up.

Getting much closer to break even here.

Still dragging the trend line flatter but closer to it than last week.
The trading account looks like this after week 246 overall and week 38 of year 5

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,652.81	(-30.4%)	+£54.61
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£75.68	(38.3%)	-£2.05
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.58	(8.9%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Nice turnaround mainly thanks to DDDD:4D Pharma, but no prospect of selling anything soon.

A nudge back upwards but a long way to go. When will I get a chance to drop that injection line a bit further?

Still a pretty steady decline for the last 3 months.

I get my FXPO:Ferrexpo special dividend next week which will be nice. I'm still watching them as I may try and buy back in if there's a bit of a drop. The chances of getting back into SBTX:SkinBioTherapeutics are looking remote now, as they have sailed higher than OPTI:Optibiotix. Although they are a great company, that price comparison makes no sense. It's just bloody typical that I've held OPTI through thick and thin and gone nowhere, but when I flog SBTX expecting it to behave the same way, I'm proved terribly wrong. I still think this push upwards will stall and I'll get a chance to buy in nearer 30p. At the moment I'd rather be increasing my holding in DDDD:4D Pharma than SBTX as it is so undervalued there has to be opportunity for a big rise. 

Really excited by TLOU:Tlou Energy at the moment too. There's momentum building, and people that got impatient and sold out are now starting to come back to the bulletin boards. If that's the case then my top-up last week may have been a rare example of good timing.